Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Immune Pharma Licenses Cancer Treatment's Latin America Rights to Pint

Immune Pharmaceuticals said today it has signed a letter of intent to license the lead asset of its oncology ...

Forward this item to a colleague:


(Separate multiple addresses by commas)